Thursday, January 09, 2014 5:01:53 PM
777
Recent PCRX News
- Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024 • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/02/2024 12:00:00 PM
- Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee • GlobeNewswire Inc. • 03/13/2024 11:00:00 AM
- Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference • GlobeNewswire Inc. • 03/06/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 08:33:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 01:03:32 PM
- Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results • GlobeNewswire Inc. • 02/29/2024 01:00:00 PM
- Pacira to Report 2023 Financial Results on Thursday February 29, 2024 • GlobeNewswire Inc. • 02/22/2024 01:00:00 PM
- Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy • GlobeNewswire Inc. • 02/15/2024 01:36:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:59:39 PM
- Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc. • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams • PR Newswire (US) • 02/01/2024 03:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:25:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:24:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:21:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:18:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 10:02:42 PM
- Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues • GlobeNewswire Inc. • 01/04/2024 10:00:41 PM
- Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 12:33:59 PM
- Pacira Appoints Frank D. Lee as Chief Executive Officer • GlobeNewswire Inc. • 12/21/2023 12:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 12:44:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/13/2023 02:41:16 PM
- Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications • GlobeNewswire Inc. • 11/10/2023 12:30:00 PM
- Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM